I just noted same thing Street Authority just published. The potential is ENDLESS, including Acquisition by larger Companies
PLUS always counts it's Chicken before they hatch. This time, it is no different
VJET is going below $35 sooner than later.
They are waiting to have a chance to Rape it down to $3. Good Luck
What an opportunity I missed, being in the Med field, and knowing they were developing Hep B treatment, not available anywhere else. HIV met it's match with GILD. I applaud you guys at Gilead.
The same characteristics are unfolding with NNVC.
I was in at $16, and still holding my 5000 shares of AMAVF